Literature DB >> 29891883

Broad phenotypes in heterozygous NR5A1 46,XY patients with a disorder of sex development: an oligogenic origin?

Núria Camats1,2, Mónica Fernández-Cancio3, Laura Audí3, André Schaller4, Christa E Flück5.   

Abstract

SF-1/NR5A1 is a transcriptional regulator of adrenal and gonadal development. NR5A1 disease-causing variants cause disorders of sex development (DSD) and adrenal failure, but most affected individuals show a broad DSD/reproductive phenotype only. Most NR5A1 variants show in vitro pathogenic effects, but not when tested in heterozygote state together with wild-type NR5A1 as usually seen in patients. Thus, the genotype-phenotype correlation for NR5A1 variants remains an unsolved question. We analyzed heterozygous 46,XY SF-1/NR5A1 patients by whole exome sequencing and used an algorithm for data analysis based on selected project-specific DSD- and SF-1-related genes. The variants detected were evaluated for their significance in literature, databases and checked in silico using webtools. We identified 19 potentially deleterious variants (one to seven per patient) in 18 genes in four 46,XY DSD subjects carrying heterozygous NR5A1 disease-causing variants. We constructed a scheme of all these hits within the landscape of currently known genes involved in male sex determination and differentiation. Our results suggest that the broad phenotype in these heterozygous NR5A1 46,XY DSD subjects may well be explained by an oligogenic mode of inheritance, in which multiple hits, individually non-deleterious, may contribute to a DSD phenotype unique to each heterozygous SF-1/NR5A1 individual.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29891883      PMCID: PMC6117353          DOI: 10.1038/s41431-018-0202-7

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  29 in total

1.  A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans.

Authors:  J C Achermann; M Ito; M Ito; P C Hindmarsh; J L Jameson
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

2.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

3.  A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation.

Authors:  X Luo; Y Ikeda; K L Parker
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

4.  Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency.

Authors:  A Biason-Lauber; E J Schoenle
Journal:  Am J Hum Genet       Date:  2000-10-18       Impact factor: 11.025

Review 5.  Molecular aspects of steroidogenic factor 1 (SF-1).

Authors:  Erling A Hoivik; Aurélia E Lewis; Linda Aumo; Marit Bakke
Journal:  Mol Cell Endocrinol       Date:  2009-07-16       Impact factor: 4.102

Review 6.  Steroidogenic factor-1 (SF-1, NR5A1) and human disease.

Authors:  Bruno Ferraz-de-Souza; Lin Lin; John C Achermann
Journal:  Mol Cell Endocrinol       Date:  2010-11-13       Impact factor: 4.102

7.  Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation.

Authors:  Mabrouka Doghman; Bonald C Figueiredo; Marco Volante; Mauro Papotti; Enzo Lalli
Journal:  Nucleic Acids Res       Date:  2013-08-01       Impact factor: 16.971

8.  Human NR5A1/SF-1 mutations show decreased activity on BDNF (brain-derived neurotrophic factor), an important regulator of energy balance: testing impact of novel SF-1 mutations beyond steroidogenesis.

Authors:  Jana Malikova; Núria Camats; Mónica Fernández-Cancio; Karen Heath; Isabel González; María Caimarí; Miguel del Campo; Marian Albisu; Stanislava Kolouskova; Laura Audí; Christa E Flück
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

Review 9.  Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals.

Authors:  Sorahia Domenice; Aline Zamboni Machado; Frederico Moraes Ferreira; Bruno Ferraz-de-Souza; Antonio Marcondes Lerario; Lin Lin; Mirian Yumie Nishi; Nathalia Lisboa Gomes; Thatiana Evelin da Silva; Rosana Barbosa Silva; Rafaela Vieira Correa; Luciana Ribeiro Montenegro; Amanda Narciso; Elaine Maria Frade Costa; John C Achermann; Berenice Bilharinho Mendonca
Journal:  Birth Defects Res C Embryo Today       Date:  2016-12

10.  267 Spanish Exomes Reveal Population-Specific Differences in Disease-Related Genetic Variation.

Authors:  Joaquín Dopazo; Alicia Amadoz; Marta Bleda; Luz Garcia-Alonso; Alejandro Alemán; Francisco García-García; Juan A Rodriguez; Josephine T Daub; Gerard Muntané; Antonio Rueda; Alicia Vela-Boza; Francisco J López-Domingo; Javier P Florido; Pablo Arce; Macarena Ruiz-Ferrer; Cristina Méndez-Vidal; Todd E Arnold; Olivia Spleiss; Miguel Alvarez-Tejado; Arcadi Navarro; Shomi S Bhattacharya; Salud Borrego; Javier Santoyo-López; Guillermo Antiñolo
Journal:  Mol Biol Evol       Date:  2016-01-13       Impact factor: 16.240

View more
  17 in total

Review 1.  Towards improved genetic diagnosis of human differences of sex development.

Authors:  Emmanuèle C Délot; Eric Vilain
Journal:  Nat Rev Genet       Date:  2021-06-03       Impact factor: 53.242

2.  Steroidogenic Factor 1 Regulation of the Hypothalamic-Pituitary-Ovarian Axis of Adult Female Mice.

Authors:  Olivia E Smith; Vickie Roussel; Fanny Morin; Luisina Ongaro; Xiang Zhou; Micka C Bertucci; Daniel J Bernard; Bruce D Murphy
Journal:  Endocrinology       Date:  2022-04-01       Impact factor: 4.736

3.  A New MAMLD1 Variant in an Infant With Microphallus and Hypospadias With Hormonal Pattern Suggesting Partial Hypogonadotropic Hypogonadism-Case Report.

Authors:  Diego Yeste; Cristina Aguilar-Riera; Gennaro Canestrino; Paula Fernández-Alvarez; María Clemente; Núria Camats-Tarruella
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

4.  Whole Exome Sequencing Points towards a Multi-Gene Synergistic Action in the Pathogenesis of Congenital Combined Pituitary Hormone Deficiency.

Authors:  Amalia Sertedaki; Elizabeth Barbara Tatsi; Ioannis Anargyros Vasilakis; Irene Fylaktou; Eirini Nikaina; Nicoletta Iacovidou; Tania Siahanidou; Christina Kanaka-Gantenbein
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

Review 5.  Development and function of the fetal adrenal.

Authors:  Emanuele Pignatti; Therina du Toit; Christa E Flück
Journal:  Rev Endocr Metab Disord       Date:  2022-10-18       Impact factor: 9.306

Review 6.  Monogenic causes of non-obstructive azoospermia: challenges, established knowledge, limitations and perspectives.

Authors:  Laura Kasak; Maris Laan
Journal:  Hum Genet       Date:  2020-01-18       Impact factor: 4.132

7.  Integrating clinical and genetic approaches in the diagnosis of 46,XY disorders of sex development.

Authors:  Zofia Kolesinska; James Acierno; S Faisal Ahmed; Cheng Xu; Karina Kapczuk; Anna Skorczyk-Werner; Hanna Mikos; Aleksandra Rojek; Andreas Massouras; Maciej R Krawczynski; Nelly Pitteloud; Marek Niedziela
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

8.  Characteristics and possible mechanisms of 46, XY differences in sex development caused by novel compound variants in NR5A1 and MAP3K1.

Authors:  Yiping Cheng; Jing Chen; Xinli Zhou; Jiangfei Yang; Yiming Ji; Chao Xu
Journal:  Orphanet J Rare Dis       Date:  2021-06-10       Impact factor: 4.123

Review 9.  GENETICS IN ENDOCRINOLOGY: Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’

Authors:  L Audi; S F Ahmed; N Krone; M Cools; K McElreavey; P M Holterhus; A Greenfield; A Bashamboo; O Hiort; S A Wudy; R McGowan
Journal:  Eur J Endocrinol       Date:  2018-10-01       Impact factor: 6.664

10.  NR5A1 gene variants repress the ovarian-specific WNT signaling pathway in 46,XX disorders of sex development patients.

Authors:  Ingrid M Knarston; Gorjana Robevska; Jocelyn A van den Bergen; Stefanie Eggers; Brittany Croft; Jason Yates; Remko Hersmus; Leendert H J Looijenga; Fergus J Cameron; Klaus Monhike; Katie L Ayers; Andrew H Sinclair
Journal:  Hum Mutat       Date:  2018-11-30       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.